Somryst— 510(k) K191716

Substantially Equivalent

Pear Therapeutics, Inc.

FDA 510(k) clearance K191716 for Somryst, Substantially Equivalent on 2020-03-23. Applicant: Pear Therapeutics, Inc..

Clearance details

Applicant: Pear Therapeutics, Inc.
Product code: Code QVO
Advisory panel: Neurology
Date received: 2019-06-26
Decision date: 2020-03-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Francisco, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.